Back to Hood River Capital Management LLC Hood River Capital Management LLC

ACADACAD
Showing 2 of 8 quarters

Position history for Hood River Capital Management LLCHood River Capital Management LLC's holdings in ACADIA PHARMACEUTICALS INC

No. Hood River Capital Management exited its ACAD (Acadia Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 469,381 shares worth $7.2M. Hood River Capital Management first reported ACAD in Q1 2020 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$7.2M

Total Shares Change

-469,381

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$18.35
0
2024-Q3
New
469,381
-
$7.2M0.1%$15.38
45

Other major holders of ACAD: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used